Katalin Csermak

646 total citations
6 papers, 324 citations indexed

About

Katalin Csermak is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Katalin Csermak has authored 6 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Genetics. Recurrent topics in Katalin Csermak's work include Chronic Lymphocytic Leukemia Research (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Protein Kinase Regulation and GTPase Signaling (1 paper). Katalin Csermak is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Protein Kinase Regulation and GTPase Signaling (1 paper). Katalin Csermak collaborates with scholars based in Switzerland, United Kingdom and United States. Katalin Csermak's co-authors include Anthony Man, P. A. Campochiaro, Martin Pruschy, Stephan Bodis, T. O'Reilly, Stephan Ruetz, Tim Meyer, J M Wood, Andres Virchis and R G Wickremasinghe and has published in prestigious journals such as BMJ Open, Malaria Journal and The Hematology Journal.

In The Last Decade

Katalin Csermak

5 papers receiving 315 citations

Peers

Katalin Csermak
Comparison fields: 5 of 49
  • Molecular Biology 157
  • Hematology 96
  • Genetics 72
  • Immunology 65
  • Oncology 57
Replace M. Georget with:
M. Georget France
Eugenio Lucia Italy
Chinmay Munje United Kingdom
Chaitanya Iragavarapu United States
Bettina Wingelhofer Austria
Xuzhang Lu China
Avinash Desai United States
Murray Yule United States
Petr Kosztyu Czechia
Elena G. Bamberger United States
M. Georget France View profile →
Citations per field, relative to Katalin Csermak
Katalin Csermak · 1×
Citations per year, relative to Katalin Csermak
Katalin Csermak · 1×

Countries citing papers authored by Katalin Csermak

Since Specialization
Citations

This map shows the geographic impact of Katalin Csermak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katalin Csermak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katalin Csermak more than expected).

Fields of papers citing papers by Katalin Csermak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katalin Csermak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katalin Csermak. The network helps show where Katalin Csermak may publish in the future.

Co-authorship network of co-authors of Katalin Csermak

This figure shows the co-authorship network connecting the top 25 collaborators of Katalin Csermak. A scholar is included among the top collaborators of Katalin Csermak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katalin Csermak. Katalin Csermak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
# Work Indexed citations
1 0
2 9
3 15
4 27
5
Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro.
40
6
PKC412--a protein kinase inhibitor with a broad therapeutic potential.
233

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026